Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022

BUY
$0.23 - $0.35 $4,647 - $7,071
20,205 New
20,205 $6,000
Q1 2022

May 17, 2022

SELL
$0.28 - $0.68 $16,247 - $39,457
-58,025 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$0.6 - $1.04 $4,438 - $7,692
7,397 Added 14.61%
58,025 $35,000
Q3 2021

Nov 16, 2021

BUY
$0.99 - $1.38 $24,242 - $33,792
24,487 Added 93.67%
50,628 $52,000
Q2 2021

Aug 16, 2021

SELL
$1.14 - $1.87 $2,310 - $3,790
-2,027 Reduced 7.2%
26,141 $33,000
Q1 2021

May 18, 2021

BUY
$1.34 - $3.53 $37,745 - $99,433
28,168 New
28,168 $50,000
Q3 2020

Nov 17, 2020

SELL
$0.93 - $1.35 $30,882 - $44,829
-33,207 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$0.97 - $1.7 $32,210 - $56,451
33,207 New
33,207 $44,000
Q4 2019

Feb 14, 2020

SELL
$1.0 - $1.49 $11,964 - $17,826
-11,964 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$0.97 - $1.77 $7,277 - $13,280
-7,503 Reduced 38.54%
11,964 $14,000
Q2 2019

Aug 15, 2019

BUY
$0.96 - $1.89 $18,688 - $36,792
19,467 New
19,467 $24,000
Q1 2019

May 16, 2019

SELL
$1.76 - $3.73 $35,244 - $74,693
-20,025 Closed
0 $0
Q4 2018

Feb 15, 2019

BUY
$2.01 - $4.21 $40,250 - $84,305
20,025 New
20,025 $74,000
Q2 2018

Aug 15, 2018

SELL
$2.05 - $4.09 $29,382 - $58,621
-14,333 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$2.12 - $7.0 $30,385 - $100,331
14,333 New
14,333 $32,000

About TYME TECHNOLOGIES, INC.


  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.